This report studies Stem Cell UCB in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Caladrius Biosciences?

Celgene?

Mesoblast?

Pluristem Therapeutics

Athersys

CHA Bio & Diostech?

Cytori Therapeutics

Nuo Therapeutics?

Ocata Therapeutics?

Opexa Therapeutics?

Osiris Therapeutics?

Teva Pharmaceuticals?

United Therapeutics?

By types, the market can be split into

Public cord blood banks

Private cord blood banks

Public Vs. Private UCB banks

By Application, the market can be split into

Therapeutics service companies

Private and government research institutes

Academic Institutes

Research based pharmaceutical companies

Public and Private cord blood banks

By Regions, this report covers (we can add the regions/countries as you want)